Divis Laboratories Ltd | DIVI - Sales Revenues


Divis Laboratories Ltd reported INR28.31B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Aurobindo Pharma INR 88.53B 2.07B Mar/2026
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 28.31B 2.27B Mar/2026
Ionis Pharmaceuticals USD 246M 43M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Lupin INR 74.75B 3.41B Mar/2026
Moderna USD 389M 289M Mar/2026
Organon & Co USD 1.46B 50M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Tilray USD 217.51M 74.75M Dec/2025
Viatris USD 3.52B 180M Mar/2026
Xeris Pharmaceuticals USD 83.13M 2.68M Mar/2026